Literature DB >> 33597854

A Critical Review of Cranial Electrotherapy Stimulation for Neuromodulation in Clinical and Non-clinical Samples.

Tad T Brunyé1,2, Joseph E Patterson2, Thomas Wooten3, Erika K Hussey1,2.   

Abstract

Cranial electrotherapy stimulation (CES) is a neuromodulation tool used for treating several clinical disorders, including insomnia, anxiety, and depression. More recently, a limited number of studies have examined CES for altering affect, physiology, and behavior in healthy, non-clinical samples. The physiological, neurochemical, and metabolic mechanisms underlying CES effects are currently unknown. Computational modeling suggests that electrical current administered with CES at the earlobes can reach cortical and subcortical regions at very low intensities associated with subthreshold neuromodulatory effects, and studies using electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) show some effects on alpha band EEG activity, and modulation of the default mode network during CES administration. One theory suggests that CES modulates brain stem (e.g., medulla), limbic (e.g., thalamus, amygdala), and cortical (e.g., prefrontal cortex) regions and increases relative parasympathetic to sympathetic drive in the autonomic nervous system. There is no direct evidence supporting this theory, but one of its assumptions is that CES may induce its effects by stimulating afferent projections of the vagus nerve, which provides parasympathetic signals to the cardiorespiratory and digestive systems. In our critical review of studies using CES in clinical and non-clinical populations, we found severe methodological concerns, including potential conflicts of interest, risk of methodological and analytic biases, issues with sham credibility, lack of blinding, and a severe heterogeneity of CES parameters selected and employed across scientists, laboratories, institutions, and studies. These limitations make it difficult to derive consistent or compelling insights from the extant literature, tempering enthusiasm for CES and its potential to alter nervous system activity or behavior in meaningful or reliable ways. The lack of compelling evidence also motivates well-designed and relatively high-powered experiments to assess how CES might modulate the physiological, affective, and cognitive responses to stress. Establishing reliable empirical links between CES administration and human performance is critical for supporting its prospective use during occupational training, operations, or recovery, ensuring reliability and robustness of effects, characterizing if, when, and in whom such effects might arise, and ensuring that any benefits of CES outweigh the risks of adverse events.
Copyright © 2021 Brunyé, Patterson, Wooten and Hussey.

Entities:  

Keywords:  electrotherapy; human performance; neuromodulation; non-invasive brain stimulation; psychiatry

Year:  2021        PMID: 33597854      PMCID: PMC7882621          DOI: 10.3389/fnhum.2021.625321

Source DB:  PubMed          Journal:  Front Hum Neurosci        ISSN: 1662-5161            Impact factor:   3.169


  4 in total

1.  In vivo Measurements of Electric Fields During Cranial Electrical Stimulation in the Human Brain.

Authors:  Minmin Wang; Tao Feng; Hongjie Jiang; Junming Zhu; Wuwei Feng; Pratik Y Chhatbar; Jianmin Zhang; Shaomin Zhang
Journal:  Front Hum Neurosci       Date:  2022-02-18       Impact factor: 3.169

2.  Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis.

Authors:  Pao-Yuan Ching; Tien-Wei Hsu; Guan-Wei Chen; Chih-Chuan Pan; Che-Sheng Chu; Po-Han Chou
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

3.  Comparison of the effects of cranial electrotherapy stimulation and midazolam as preoperative treatment in geriatric patients: A CONSORT-compliant randomized controlled trial.

Authors:  Byeong Seon Park; Sejong Jin; Woon Young Kim; Da Som Kang; Yoon Ji Choi; Yoon Sook Lee
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

4.  Lesions causing central sleep apnea localize to one common brain network.

Authors:  Taoyang Yuan; Zhentao Zuo; Jianguo Xu
Journal:  Front Neuroanat       Date:  2022-09-29       Impact factor: 3.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.